Evaluating Parent Delivered Interventions for Children With Autism
1 other identifier
interventional
104
1 country
1
Brief Summary
The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and child functioning before and after intervention, the investigators will be able to determine whether the intervention is effective in improving child social communication and reducing parent stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 17, 2013
CompletedFirst Posted
Study publicly available on registry
June 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2022
CompletedJuly 14, 2023
July 1, 2023
12.1 years
June 17, 2013
July 13, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Change in CGI-S (Clinical Global Impression - Severity)
Difference from Baseline to Week 12
Change in SRS (Social Responsiveness Scale)
Difference from Baseline to Week 12
Change in CDI (Communicative Development Survey) Score
Difference from Baseline to Week 12
Change in social and communication behaviors as assessed by standardized laboratory observations
Difference from Baseline to Week 12
Secondary Outcomes (6)
Change in VABS (Vineland Adaptive Behavior Scale) Score
Difference from Baseline to Week 12
Change in social and communication behaviors as assessed from home videos
Difference from Baseline to Week 12
Change in PSI (Parenting Stress Index) Score
Difference from Baseline to Week 12
Change in FES (Family Empowerment Scale) Score
Difference from Baseline to Week 12
Change in frequency and duration of investigation therapy
Difference from Baseline to Week 12
- +1 more secondary outcomes
Study Arms (2)
Developmentally Based Intervention
EXPERIMENTALBehaviorally Based Intervention
EXPERIMENTALInterventions
The behaviorally-based intervention is a treatment model that uses the principles of Applied Behavior Analysis (Koegel, Openden, Fredeen, \& Koegel, 2006) to increase children's adaptive behaviors and decrease maladaptive behaviors.
The developmentally based intervention is grounded in a development theory, that focuses on child-directed interactions with warm and caring individuals that aid in acquiring missed developmental and functional milestones.
The hybrid based treatment has an eclectic approach that incorporates both systematic (behaviorally-based) and affect-based learning (developmentally-based)that focuses on increasing children's skill development (http://www.pacificautism.org).
Eligibility Criteria
You may qualify if:
- Children between the ages of 1.6 and 17.11 years of age
- Males and females
- Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed
- Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder
- Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject
- Will have an age range between 1.6 and 17.11 years of age
- Males or females
- Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation
- Have historical evidence of significant abnormal developmental milestones as determined by neurological history
- Receiving or will receive a parent delivered intervention
- Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject
You may not qualify if:
- Is medically unstable (e.g., more than one seizure a month)
- Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder)
- Is medically unstable (e.g., more than one seizure a month)
- Has a diagnosis of ASD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Y Hardan, M.D.
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 17, 2013
First Posted
June 20, 2013
Study Start
February 1, 2010
Primary Completion
February 18, 2022
Study Completion
February 18, 2022
Last Updated
July 14, 2023
Record last verified: 2023-07